Vaccination against hepatitis B as prevention for hepatocellular carcinoma

被引：0
作者：
Dietz, Christopher A. [1 ]
Wedemeyer, Heiner [1 ]
机构：
[1] Hannover Med Sch, Klin Gastroenterol Hepatol & Endokrinol, Carl Neuberg Str 1, D-30625 Hannover, Germany
来源：
ONKOLOGE | 2022年 / 28卷 / 01期
关键词：
Hepatitis C; Liver cirrhosis; Chronic hepatitis; Liver neoplasms; Viral hepatitis; human; VIRUS INFECTION; DISEASE;
D O I：
10.1007/s00761-021-01036-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background Chronic infection with the hepatitis B virus (HBV) is an important risk factor for the development of hepatocellular carcinoma (HCC). Even though treatment options for HCC are constantly improving, preventive measures must not be neglected. Conclusion The vaccination against hepatitis B has proven effective in preventing infection with HBV. As shown more than 20 years ago in Taiwan, vaccination programs lower not only the prevalence of HBsAg carriers but also decrease the incidence of HCC. By achieving immunity against HBV, the infection with hepatitis D virus can also be prevented. This is important in the light of HCC prevention as HBV/HDV coinfection is known to drastically increase the risk of HCC. New approaches aim for the development of therapeutic HBV vaccines ideally curing chronic infections. Beside the prevention of infections, it is pivotal to detect existing infections. This helps to minimize the HCC risk by initiating treatment in those who need it.
引用
收藏
页码：15 / 22
页数：8
相关论文
共 30 条
  • [1] The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015
    Akinyemiju, Tomi
    Abera, Semaw
    Ahmed, Muktar
    Alam, Noore
    Alemayohu, Mulubirhan Assefa
    Allen, Christine
    Al-Raddadi, Rajaa
    Alvis-Guzman, Nelson
    Amoako, Yaw
    Artaman, Al
    Ayele, Tadesse Awoke
    Barac, Aleksandra
    Bensenor, Isabela
    Berhane, Adugnaw
    Bhutta, Zulfiqar
    Castillo-Rivas, Jacqueline
    Chitheer, Abdulaal
    Choi, Jee-Young
    Cowie, Benjamin
    Dandona, Lalit
    Dandona, Rakhi
    Dey, Subhojit
    Dicker, Daniel
    Phuc, Huyen
    Ekwueme, Donatus U.
    Zaki, Maysaa El Sayed
    Fischer, Florian
    Furst, Thomas
    Hancock, Jamie
    Hay, Simon I.
    Hotez, Peter
    Jee, Sun Ha
    Kasaeian, Amir
    Khader, Yousef
    Khang, Young-Ho
    Kumar, G. Anil
    Kutz, Michael
    Larson, Heidi
    Lopez, Alan
    Lunevicius, Raimundas
    Malekzadeh, Reza
    McAlinden, Colm
    Meier, Toni
    Mendoza, Walter
    Mokdad, Ali
    Moradi-Lakeh, Maziar
    Nagel, Gabriele
    Nguyen, Quyen
    Nguyen, Grant
    Ogbo, Felix
    [J]. JAMA ONCOLOGY, 2017, 3 (12) : 1683 - 1691
  • [2] Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studies
    Alfaiate, Dulce
    Clement, Sophie
    Gomes, Diana
    Goossens, Nicolas
    Negro, Francesco
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 (03) : 533 - 539
  • [3] Approaches, Progress, and Challenges to Hepatitis C Vaccine Development
    Bailey, Justin R.
    Barnes, Eleanor
    Cox, Andrea L.
    [J]. GASTROENTEROLOGY, 2019, 156 (02) : 418 - 430
  • [4] Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children
    Chang, MH
    Chen, CJ
    Lai, MS
    Hsu, HM
    Wu, TC
    Kong, MS
    Liang, DC
    Shau, WY
    Chen, DS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (26) : 1855 - 1859
  • [5] Seroepidemiology of hepatitis B virus infection in children - Ten years of mass vaccination in Taiwan
    Chen, HL
    Chang, MH
    Ni, YH
    Hsu, HY
    Lee, PI
    Lee, CY
    Chen, DS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (11): : 906 - 908
  • [6] S3 Guideline of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS) for the Prophylaxis, Diagnosis and Therapy of Hepatitis B Virus Infection (AWMF Register No. 021-11)
    Cornberg, Markus
    Sandmann, Lisa
    Protzer, Ulrike
    Niederau, Claus
    Tacice, Frank
    Berg, Thomas
    Glebe, Dieter
    Jilg, Wolfgang
    VVedemeyer, Heiner
    VVirth, Stefan
    Siederdissen, Christoph Hoener zu
    Lynen-Jansen, Petra
    van Leeuwen, Pia
    Petersen, Joerg
    Ciesek, Sandra
    Timm, Joerg
    Knop, Viola
    Schirrnacher, Peter
    Schuettler, Christian
    Buggisch, Peter
    Tannapfel, Andrea
    Jochum, Christoph
    Hinrichsen, Holger
    Kautz, Achim
    Peiffer, Kai-Henrik
    Sarrazin, Christoph
    Schott, Eckart
    Dikopoulos, Nektarios
    Kroy, Daniela
    Sprinzl, Martin
    van Bornmel, Florian
    van Thiel, Ingo
    Vermehren, Johannes
    Wursthorn, Karsten
    Zeuzem, Stefan
    Manns, Michael P.
    Berg, Christoph
    Herzer, Kerstin
    Maasoumy, Benjamin
    Sterneck, Martina
    Aehling, Niklas
    Trowe, Eqbert
    Strassburg, Christian
    Gerlich, Wolfram
    Kallinowski, Birgit
    zur Wiesch, Julian Schulze
    Verheyen, Jens
    Wicker, Sabine
    Wranlce, Anika
    Klinker, Hartwig
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2021, 59 (07): : 691 - 776
  • [7] New therapeutic options for hepatitis D
    Deterding K.
    Wedemeyer H.
    [J]. MMW - Fortschritte der Medizin, 2021, 163 (12) : 62 - 63
  • [8] European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019
  • [9] Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors
    Fattovich, Giovanna
    Bortolotti, Flavia
    Donato, Francesco
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 (02) : 335 - 352
  • [10] Designing the next-generation therapeutic vaccines to cure chronic hepatitis B: focus on antigen presentation, vaccine properties and effect measures
    Jansen, Diahann T. S. L.
    Dou, Yingying
    de Wilde, Janet W.
    Woltman, Andrea M.
    Buschow, Sonja, I
    [J]. CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2021, 10 (01)
123